COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients

To our knowledge, this is the first systematic review evaluating COVID-19 phenotype and outcomes in immunocompromised patients and comparing them to the general population, which shows that hospital outcomes appear to be worse in adult CA and SOT patients, potentially due to their higher co-morbidity burden.

Source: Journal of Infection - February 3, 2021 Category: Infectious Diseases Authors: Jennifer A. Belsky, Brian P. Tullius, Margaret G. Lamb, Rouba Sayegh, Joseph R. Stanek, Jeffery J. Auletta Source Type: research